Symbols / PHIO Stock $1.25 +3.75% Phio Pharmaceuticals Corp.

Healthcare • Biotechnology • United States • NCM
PHIO (Stock) Chart
About

Phio Pharmaceuticals Corp., a clinical stage biopharmaceutical company, engages in the development of immuno-oncology therapeutics in the United States. It develops PH-762, an INTASYL compound designed to reduce the expression of PD-1 in multi-center Phase 1b dose-escalating clinical trials; PH-894, an INTASYL compound that is designed to specifically silence BRD4, a protein that controls gene expression in both T cells and tumor cells in preclinical studies. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was founded in 2003 and is based in King Of Prussia, Pennsylvania.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Biotechnology Market Cap 14.46M
Enterprise Value -7.09M Income -8.70M Sales —
Book/sh 1.73 Cash/sh 1.81 Dividend Yield —
Payout 0.00% Employees 6 IPO —
P/E — Forward P/E -2.01 PEG —
P/S — P/B 0.72 P/C —
EV/EBITDA 0.77 EV/Sales — Quick Ratio 15.70
Current Ratio 16.03 Debt/Eq — LT Debt/Eq —
EPS (ttm) -1.45 EPS next Y -0.62 EPS Growth —
Revenue Growth — Earnings 2026-03-05 16:00 ROA -42.33%
ROE -69.95% ROIC — Gross Margin 0.00%
Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 11.62M
Shs Float 11.55M Short Float 5.07% Short Ratio 0.30
Short Interest — 52W High 4.19 52W Low 0.81
Beta 0.91 Avg Volume 3.84M Volume 65.32K
Target Price $14.00 Recom None Prev Close $1.20
Price $1.25 Change 3.75%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$14.00
Mean price target
2. Current target
$1.24
Latest analyst target
3. DCF / Fair value
$-7.83
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.24
Low
$14.00
High
$14.00
Mean
$14.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-02-10 reit HC Wainwright & Co. Buy → Buy $14
2025-08-15 reit HC Wainwright & Co. Buy → Buy $14
2025-06-25 reit HC Wainwright & Co. Buy → Buy $14
2025-04-08 reit HC Wainwright & Co. Buy → Buy $4
2025-02-19 reit HC Wainwright & Co. Buy → Buy $4
2024-05-14 reit HC Wainwright & Co. Buy → Buy $4
2024-02-06 main HC Wainwright & Co. Buy → Buy $4
2023-08-16 reit HC Wainwright & Co. Buy → Buy $6
News
RSS: Latest PHIO news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-02-05 BITTERMAN ROBERT J Chief Executive Officer — 120,000 $0.00 $0
2026-02-05 BRADFORD PATRICIA A Director — 18,500 $0.00 $0
2026-02-05 LOCKSHIN CURTIS Director — 16,600 $0.00 $0
2026-02-05 DEMING DAVID H Director — 23,800 $0.00 $0
2026-02-05 FREEMAN JONATHAN E PH.D. Director — 16,600 $0.00 $0
2026-02-05 CARSON LISA CABOTT Chief Financial Officer — 47,000 $0.00 $0
2025-12-31 BITTERMAN ROBERT J Chief Executive Officer — 5,000 $1.03 $5,150
2025-12-23 BITTERMAN ROBERT J Chief Executive Officer — 5,000 $1.02 $5,100
2025-11-21 BITTERMAN ROBERT J Chief Executive Officer — 5,000 $1.14 $5,700
2025-11-18 BITTERMAN ROBERT J Chief Executive Officer — 5,000 $1.27 $6,350
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
9.22
+24.81%
7.39
-30.95%
10.70
-6.67%
11.46
Research And Development
4.62
+26.76%
3.64
-42.47%
6.33
-9.70%
7.01
Selling General And Administration
4.60
+22.92%
3.74
-14.25%
4.37
-1.89%
4.45
General And Administrative Expense
4.60
+22.92%
3.74
-14.25%
4.37
-1.89%
4.45
Other Gand A
4.60
+22.92%
3.74
-14.25%
4.37
-1.89%
4.45
Total Expenses
9.22
+24.81%
7.39
-30.95%
10.70
-6.67%
11.46
Operating Income
-9.22
-24.81%
-7.39
+30.95%
-10.70
+6.67%
-11.46
Total Operating Income As Reported
-9.22
-24.81%
-7.39
+31.75%
-10.82
+5.57%
-11.46
EBITDA
-9.22
-25.37%
-7.35
+30.07%
-10.51
+6.70%
-11.27
Normalized EBITDA
-9.22
-25.37%
-7.35
+29.23%
-10.39
+7.82%
-11.27
Reconciled Depreciation
0.00
-91.43%
0.04
-80.98%
0.18
-4.66%
0.19
EBIT
-9.22
-24.81%
-7.39
+30.95%
-10.70
+6.67%
-11.46
Total Unusual Items
—
0.00
+100.00%
-0.13
0.00
Total Unusual Items Excluding Goodwill
—
0.00
+100.00%
-0.13
0.00
Special Income Charges
—
0.00
+100.00%
-0.13
0.00
Other Special Charges
—
—
—
—
Impairment Of Capital Assets
—
0.00
-100.00%
0.13
0.00
Net Income
-8.70
-21.65%
-7.15
+33.96%
-10.83
+5.70%
-11.48
Pretax Income
-8.70
-21.65%
-7.15
+33.96%
-10.83
+5.70%
-11.48
Net Non Operating Interest Income Expense
0.52
+125.11%
0.23
+2987.50%
-0.01
—
Net Interest Income
0.52
+125.11%
0.23
+2987.50%
-0.01
—
Other Income Expense
0.00
-66.67%
0.01
+105.00%
-0.12
-566.67%
-0.02
Other Non Operating Income Expenses
0.00
-66.67%
0.01
+0.00%
0.01
+133.33%
-0.02
Tax Provision
—
—
—
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-8.70
-21.65%
-7.15
+33.96%
-10.83
+5.70%
-11.48
Net Income From Continuing Operation Net Minority Interest
-8.70
-21.65%
-7.15
+33.96%
-10.83
+5.70%
-11.48
Net Income From Continuing And Discontinued Operation
-8.70
-21.65%
-7.15
+33.96%
-10.83
+5.70%
-11.48
Net Income Continuous Operations
-8.70
-21.65%
-7.15
+33.96%
-10.83
+5.70%
-11.48
Normalized Income
-8.70
-21.65%
-7.15
+33.18%
-10.70
+6.79%
-11.48
Net Income Common Stockholders
-8.70
-21.65%
-7.15
+33.96%
-10.83
+5.70%
-11.48
Diluted EPS
—
-9.08
+80.58%
-46.76
+48.54%
-90.86
Basic EPS
—
-9.08
+80.58%
-46.76
+48.54%
-90.86
Basic Average Shares
—
0.79
+240.15%
0.23
+83.25%
0.13
Diluted Average Shares
—
0.79
+240.15%
0.23
+83.25%
0.13
Diluted NI Availto Com Stockholders
-8.70
-21.65%
-7.15
+33.96%
-10.83
+5.70%
-11.48
Total Other Finance Cost
-0.52
-125.11%
-0.23
-2987.50%
0.01
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
21.49
+274.47%
5.74
-38.72%
9.36
-26.92%
12.81
Current Assets
21.48
+274.41%
5.74
-38.47%
9.32
-25.10%
12.45
Cash Cash Equivalents And Short Term Investments
21.03
+290.77%
5.38
-36.61%
8.49
-27.93%
11.78
Cash And Cash Equivalents
21.03
+290.77%
5.38
-36.61%
8.49
-27.93%
11.78
Cash Financial
21.03
+290.77%
5.38
-36.61%
8.49
-27.93%
11.78
Prepaid Assets
—
—
—
—
Restricted Cash
—
—
0.00
-100.00%
0.05
Other Current Assets
0.45
+25.71%
0.35
-57.45%
0.83
+35.28%
0.61
Total Non Current Assets
0.01
+450.00%
0.00
-95.24%
0.04
-88.59%
0.37
Net PPE
0.01
+450.00%
0.00
-94.87%
0.04
-88.66%
0.34
Gross PPE
0.24
-22.40%
0.31
-73.79%
1.18
-22.65%
1.52
Accumulated Depreciation
-0.23
+25.49%
-0.31
+73.06%
-1.14
+3.32%
-1.18
Properties
—
0.00
0.00
0.00
Machinery Furniture Equipment
0.24
-22.40%
0.31
-71.90%
1.10
-16.46%
1.31
Other Properties
—
—
0.03
-79.50%
0.16
Leases
—
0.00
-100.00%
0.05
+0.00%
0.05
Other Non Current Assets
—
—
0.00
-87.50%
0.02
Total Liabilities Net Minority Interest
1.34
+32.02%
1.01
-37.88%
1.63
-17.31%
1.98
Current Liabilities
1.34
+32.02%
1.01
-37.88%
1.63
-15.73%
1.94
Payables And Accrued Expenses
1.34
+32.02%
1.01
-26.29%
1.38
-1.36%
1.40
Payables
0.43
+71.94%
0.25
-61.49%
0.66
-15.66%
0.78
Accounts Payable
0.43
+71.94%
0.25
-61.49%
0.66
-15.66%
0.78
Current Accrued Expenses
0.91
+18.77%
0.76
+5.83%
0.72
+16.69%
0.62
Pensionand Other Post Retirement Benefit Plans Current
—
0.03
-86.04%
0.22
-45.59%
0.41
Current Debt And Capital Lease Obligation
—
—
0.04
-74.07%
0.14
Current Capital Lease Obligation
—
0.00
-100.00%
0.04
-74.07%
0.14
Other Current Liabilities
—
—
—
0.02
Total Non Current Liabilities Net Minority Interest
0.00
0.00
0.00
-100.00%
0.04
Long Term Debt And Capital Lease Obligation
—
—
0.00
-100.00%
0.04
Long Term Capital Lease Obligation
—
—
0.00
-100.00%
0.04
Preferred Securities Outside Stock Equity
0.00
0.00
0.00
-100.00%
0.00
Stockholders Equity
20.15
+326.57%
4.72
-38.90%
7.73
-28.68%
10.84
Common Stock Equity
20.15
+326.57%
4.72
-38.90%
7.73
-28.68%
10.84
Capital Stock
0.00
0.00
0.00
0.00
Common Stock
0.00
0.00
0.00
0.00
Preferred Stock
—
—
—
—
Share Issued
11.62
+570.58%
1.73
+316.08%
0.42
+228.99%
0.13
Ordinary Shares Number
11.62
+570.58%
1.73
+316.08%
0.42
+228.99%
0.13
Additional Paid In Capital
175.20
+15.97%
151.08
+2.82%
146.94
+5.54%
139.22
Retained Earnings
-155.05
-5.94%
-146.36
-5.14%
-139.21
-8.43%
-128.38
Total Equity Gross Minority Interest
20.15
+326.57%
4.72
-38.90%
7.73
-28.68%
10.84
Total Capitalization
20.15
+326.57%
4.72
-38.90%
7.73
-28.68%
10.84
Working Capital
20.14
+326.52%
4.72
-38.59%
7.69
-26.83%
10.51
Invested Capital
20.15
+326.57%
4.72
-38.90%
7.73
-28.68%
10.84
Total Debt
—
0.00
-100.00%
0.04
-79.41%
0.17
Capital Lease Obligations
—
0.00
-100.00%
0.04
-79.41%
0.17
Net Tangible Assets
20.15
+326.57%
4.72
-38.90%
7.73
-28.68%
10.84
Tangible Book Value
20.15
+326.57%
4.72
-38.90%
7.73
-28.68%
10.84
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-7.98
-12.19%
-7.11
+33.84%
-10.75
+11.38%
-12.13
Cash Flow From Continuing Operating Activities
-7.98
-12.19%
-7.11
+33.84%
-10.75
+11.38%
-12.13
Net Income From Continuing Operations
-8.70
-21.65%
-7.15
+33.96%
-10.83
+5.70%
-11.48
Depreciation Amortization Depletion
0.00
-91.43%
0.04
-80.98%
0.18
-4.66%
0.19
Depreciation
0.00
-91.43%
0.04
-80.98%
0.18
-4.66%
0.19
Depreciation And Amortization
0.00
-91.43%
0.04
-80.98%
0.18
-4.66%
0.19
Other Non Cash Items
—
—
—
—
Stock Based Compensation
0.48
+227.21%
0.15
-51.49%
0.30
-26.81%
0.41
Asset Impairment Charge
—
0.00
-100.00%
0.13
0.00
Operating Gains Losses
—
-0.01
—
—
Gain Loss On Sale Of PPE
0.00
+100.00%
-0.01
0.00
—
Change In Working Capital
0.23
+270.29%
-0.14
+74.25%
-0.54
+57.32%
-1.26
Change In Prepaid Assets
-0.09
-118.92%
0.48
+345.41%
-0.20
-2550.00%
0.01
Change In Payables And Accrued Expense
0.33
+155.82%
-0.58
-184.88%
-0.20
+82.00%
-1.14
Change In Accrued Expense
0.14
+179.44%
-0.18
-116.87%
-0.08
+94.92%
-1.64
Change In Payable
0.18
+145.30%
-0.40
-231.15%
-0.12
-124.60%
0.50
Change In Account Payable
0.18
+145.30%
-0.40
-231.15%
-0.12
-124.60%
0.50
Change In Other Current Liabilities
0.00
+100.00%
-0.04
+74.07%
-0.14
-8.00%
-0.12
Investing Cash Flow
-0.01
-250.00%
0.01
+260.00%
-0.01
+95.87%
-0.12
Cash Flow From Continuing Investing Activities
-0.01
-250.00%
0.01
+260.00%
-0.01
+95.87%
-0.12
Net PPE Purchase And Sale
-0.01
-1100.00%
-0.00
+80.00%
-0.01
+95.87%
-0.12
Purchase Of PPE
-0.01
-1100.00%
-0.00
+80.00%
-0.01
+95.87%
-0.12
Capital Expenditure
-0.01
-1100.00%
-0.00
+80.00%
-0.01
+95.87%
-0.12
Net Other Investing Changes
—
0.01
—
—
Financing Cash Flow
23.64
+491.59%
4.00
-46.09%
7.41
+28611.54%
-0.03
Cash Flow From Continuing Financing Activities
23.64
+491.59%
4.00
-46.09%
7.41
+28611.54%
-0.03
Net Issuance Payments Of Debt
—
—
—
—
Issuance Of Debt
—
—
—
—
Repayment Of Debt
—
—
—
—
Long Term Debt Issuance
—
—
—
—
Long Term Debt Payments
—
—
—
—
Net Long Term Debt Issuance
—
—
—
—
Net Common Stock Issuance
17.91
+1791600.00%
-0.00
-100.01%
7.44
0.00
Common Stock Payments
0.00
+100.00%
-0.00
+90.91%
-0.01
0.00
Repurchase Of Capital Stock
0.00
+100.00%
-0.00
+92.31%
-0.01
0.00
Proceeds From Stock Option Exercised
5.75
+43.80%
4.00
—
0.00
Net Other Financing Charges
-0.03
-500.00%
-0.01
+80.77%
-0.03
+7.14%
-0.03
Changes In Cash
15.65
+603.51%
-3.11
+6.97%
-3.34
+72.78%
-12.28
Beginning Cash Position
5.38
-36.61%
8.49
-28.24%
11.83
-50.92%
24.11
End Cash Position
21.03
+290.77%
5.38
-36.61%
8.49
-28.24%
11.83
Free Cash Flow
-7.99
-12.34%
-7.11
+33.86%
-10.75
+12.21%
-12.25
Interest Paid Supplemental Data
0.00
-100.00%
0.01
+18.18%
0.01
—
Common Stock Issuance
17.91
0.00
-100.00%
7.45
0.00
Issuance Of Capital Stock
17.91
0.00
-100.00%
7.45
+372500.00%
0.00
Net Preferred Stock Issuance
—
0.00
+100.00%
-0.00
-200.00%
0.00
Preferred Stock Issuance
—
—
0.00
-100.00%
0.00
Preferred Stock Payments
—
0.00
+100.00%
-0.00
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category